ScholarIQanswers from OpenAlex
ERN GUARD-Heart
InstitutionResearch output, impact & collaborations
ERN GUARD-Heart is a institution indexed in ScholarIQ from OpenAlex.
What is known about ERN GUARD-Heart?
ScholarIQrecord summary
ERN GUARD-Heart is a research organisation in Amsterdam, NL. OpenAlex records 1,716 works and 136,676 citations for it. 958 researchers list it as their most recent affiliation.
How many works does ERN GUARD-Heart have?
ScholarIQindexed works
ERN GUARD-Heart has 1,716 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does ERN GUARD-Heart have?
ScholarIQcitation count
ERN GUARD-Heart has 136,676 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at ERN GUARD-Heart?
ScholarIQresearcher count
ERN GUARD-Heart has 958 researchers in the ScholarIQ index.
What is the average h-index at ERN GUARD-Heart?
ScholarIQavg h-index
ERN GUARD-Heart has an average h-index of 73 in OpenAlex.
What is the ROR of ERN GUARD-Heart?
ScholarIQror
The ROR for ERN GUARD-Heart is on the source record.
What is the OpenAlex record for ERN GUARD-Heart?
ScholarIQopenalex
The OpenAlex for ERN GUARD-Heart is on the source record.
Who are the most-cited researchers behind ERN GUARD-Heart?
ScholarIQtop researchers by citations
What are the most-cited papers on ERN GUARD-Heart?
ScholarIQmost cited works
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Alida L.P. Caforio, Sabine Pankuweit, Eloisa Arbustini, Cristina Basso, Juan R. Gimeno, Stephan B. Felix, Michael Fu, Tiina Heliö, Stéphane Heymans, Roland Jahns, Karin Klingel, Aleš Linhart, Bernhard Maisch, William J. McKenna, Jens Mogensen, Yigal M. Pinto, Arsen Ristić, Heinz‐Peter Schultheiß, Hubert Seggewiß, Luigi Tavazzi, Gaetano Thiene, Atilla Yılmaz, Philippe Charron, Perry Elliott
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, María J. Perugorria, Luca Fabris, Luke Boulter, Rocı́o I.R. Macı́as, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie K. Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa, Theodore P. Abraham, Ahmad Masri, Pablo García‐Pavía, Sara Saberi, Neal K. Lakdawala, Matthew T. Wheeler, Anjali Owens, Miloš Kubánek, Wojciech Wojakowski, Morten K. Jensen, Juan R. Gimeno, Kia Afshar, Jonathan Myers, Sheila M. Hegde, Scott D. Solomon, Amy J. Sehnert, David Zhang, Wanying Li, Mondira Bhattacharya, Jay M. Edelberg, Cynthia Burstein Waldman, Steven J. Lester, Andrew Wang, Carolyn Y. Ho, Daniel Jacoby, Jozef Bartúnek, Antoine Bondue, Emeline M. Van Craenenbroeck, Miloš Kubánek, David Zemánek, Morten K. Jensen, Jens Mogensen, Jens Jakob Thune, Philippe Charron, Albert Hagège, Olivier Lairez, Jean‐Noël Trochu, Christoph Axthelm, H DUENGEN, Norbert Frey, Veselin Mitrović, Michael R. Preusch, Jeanette Schulz‐Menger, Tim Seidler, Michael Arad, Majdi Halabi, Amos Katz, Daniel Monakier, Offir Paz, Samuel Viskin, Donna R. Zwas, Iacopo Olivotto, Hans‐Peter Brunner‐La Rocca, Michelle Michels, Dariusz Dudek, Zofia Oko‐Sarnowska, Artur Oręziak, Wojciech Wojakowski, Nuno Cardim, Helder Pereira, Roberto Barriales‐Villa, Pablo García Pavía, Juan Gimeno Blanes, Rafael Hidalgo Urbano, Luis Miguel Rincón Diaz, Perry Elliott, Zaheer Yousef, Theodore P. Abraham, Kia Afshar, Paulino Álvarez, Richard G. Bach, Richard C. Becker, Lubna Choudhury, David Fermin, Daniel Jacoby, John L. Jefferies, Christopher M. Kramer, Neal K. Lakdawala, Steven J. Lester, Ali J. Marian, Ahmad Masri, Matthew J. Maurer, Sherif F. Nagueh, Anjali Owens, David S. Owens, Florian Rader, Sara Saberi, Mark V. Sherrid, Jamshid Shirani, John D. Symanski, Aslan T. Turer, Andrew Wang, Omar Wever‐Pinzon, Matthew T. Wheeler, Timothy C. Wong, Mohamad H. Yamani
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Frederik Nevens, Pietro Andreoné, G. Mazzella, Simone I. Strasser, Christopher L. Bowlus, Pietro Invernizzi, Joost P.H. Drenth, Paul J. Pockros, Jarosław Reguła, Ulrich Beuers, Michael Trauner, David Jones, Annarosa Floreani, Simon Hohenester, Velimir A. Luketic, Mitchell L. Shiffman, Karel J. van Erpecum, Vı́ctor Vargas, Catherine Vincent, Gideon M. Hirschfield, Hemant Shah, Bettina E. Hansen, Keith D. Lindor, Hanns–Ulrich Marschall, Kris V. Kowdley, Roya Hooshmand-Rad, Tonya Marmon, Shawn Sheeron, Richard Pencek, Leigh MacConell, Mark Pruzanski, Д. А. Шапиро
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Tobias J. Weismüller, Palak Trivedi, Annika Bergquist, Mohamad Imam, Henrike Lenzen, Cyriel Y. Ponsioen, Kristian Holm, Daniel Gotthardt, Martti Färkkilâ, Hanns–Ulrich Marschall, Douglas Thorburn, Rinse K. Weersma, Johan Fevery, Tobias Mueller, Olivier Chazouillères, Kornelius Schulze, Konstantinos N. Lazaridis, Sven Almér, Stephen P. Pereira, Cynthia Levy, Andrew L. Mason, Sigrid Næss, Christopher L. Bowlus, Annarosa Floreani, Emina Halilbasic, Kidist Yimam, Piotr Milkiewicz, Ulrich Beuers, Dep Huynh, Albert Parés, Christine N. Manser, George Ν. Dalekos, Bertus Eksteen, Pietro Invernizzi, Christoph P. Berg, Gabi I. Kirchner, Christoph Sarrazin, Vincent Zimmer, Luca Fabris, Felix Braun, Marco Marzioni, Brian D. Juran, Karouk Said, Christian Rupp, Kalle Jokelainen, M Valle, Francesca Saffioti, Angela Cheung, Michael Trauner, Christoph Schramm, Roger W. Chapman, Tom H. Karlsen, Erik Schrumpf, Christian P. Strassburg, Michael P. Manns, Keith D. Lindor, Gideon M. Hirschfield, Bettina E. Hansen, Kirsten Muri Boberg
How much of the research on ERN GUARD-Heart is open access?
ScholarIQopen access share
92%OPEN ACCESS